Spring 2022 Symposium & Workshop: Precision Medicine Applications in Radiation Oncology

November 22, 2021

Event Dates: March 6-8th, 2022

The 18th Ci4CC Symposium will return to an in-person event at the Ritz Carlton in Santa Barbara, CA March 6-8, 2022! Ci4CC is the premier society for cancer precision medicine and informatics and provides a focused forum for professionals at NCI Designated & Community Cancer Centers with emphases on precision medicine, data science (including machine learning and AI), healthcare IT, translational research, & digital platforms. This non-profit society includes executive informatics, healthcare & research IT leaders nationally as its members and invites others including thought leaders in the specific symposium topics and themes to its programs.

The Spring 2022 Ci4CC Symposium is entitled “Precision Medicine Applications in Radiation Oncology”. Co-chaired by Drs. Quynh Thu Le of Stanford University and NRG Oncology and Wally Curran of GenesisCare and Emory University, the symposium will focus on four themes:

  1. Biomarker development for precision radiation oncology, chaired by Drs. Max Diehn (Stanford U) and Felix Feng (UCSF).

  2. Use of real-world data in cancer clinical trial design, led by David Jaffray (MD Anderson) / Michael Gensheimer (Stanford U).

  3. Use of new imaging tools and advanced analytics in theranostic, led by Drs. Daniel Pryma (U Penn) and Nat Lenzo (GenesisCare and Univ of Western Australia)

  4. Role of machine learning and AI for radiation therapy workflow, chaired by Lei Xing (Stanford U) and Steve Jiang (UT Southwestern)

Further information will be available including registration details at https://www.ci4cc.org/ 

 

Participate in RTOG Research

To participate as an RTOG study investigator, your organization must be part of the RTOG Foundation network. Patients who wish to participate in a study must be under the care of an RTOG participating investigator. For additional information, email info@rtog.org or call 1-215-574-3173.

See our clinical trials